MGNX 3.18 (+0%)
US5560991094BiotechnologyBiotechnology

Macrogenics (MGNX) Stock Highlights

3.18 | +0%
2024-12-21 06:04:09
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The companys strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The companys intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.

Statistics

Range Today
3.13 3.26
Volume Today 722.1K
Range 1 Year
2.95 21.88
Volume 1 Year 340.73M
Range 3 Year
2.13 21.88
Volume 3 Year 711.42M
Range 10 Year
2.13 39.9
Volume 10 Year 1.69B

Highlights

Market Capitalization 279.93M (small)
Floating Shares 51.74M
Current Price 3.18
Price To Earnings -2.91
Price To Revenue 0.76
Price To Book 2.27
Earnings Per Share -1.53
Payout Ratio 0%

Performance

Latest 0%
1 Month -9.14%
3 Months -5.92%
6 Months -22.82%
1 Year -68.45%
3 Years -81.03%
5 Years -71.09%
10 Years -91.26%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.